Entries by Ayal Ronen

Webinar: Cancer Non-dilutive Funding, Wed – July 31st, 2013

NIH alone awards roughly $5.8B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle with an emphasis on pre-clinical work, and may cover clinical stage activities as well. In the upcoming webinar in the series of summer educational webinars, FreeMind’s VP, Ayal Ronen, will discuss key […]

Webinar: Biodefense and Infectious Diseases Webinar

The National Institute of Allergies and Infectious Diseases (NIAID) awards close to $6,000,000,000 annually. Taking into account activities by DTRA, DARPA, US Army, BARDA etc. this is a funding force no one in the field can afford to ignore. In our first Webinar, FreeMind’s VP Ayal Ronen will discuss Biodefense and Infectious Diseases funding opportunities […]

FreeMind featured in ‘Nature’ – Grant applications: Find me the money

Lucas Laursen Nature 486, 559-561 (2012) doi:10.1038/nj7404-559a Published online 27 June 2012 This article was originally published in the journal Nature Some consultants offer to help researchers to find and secure grants. But scientists should carefully consider whether and how a consultant is worth the time and expense. Read article online The e-mails were arriving in […]

Turning Non-Dilutive Funding into a Strategic Source of Funding

Non dilutive R&D funding – mainly multibillion programs of Federal agencies – has become a major player in the life science finance industry. Today more than ever, NIH, DOD, NSF, CDC and dozens of other agencies, both federal and private, support biological and medical preclinical and clinical activities in all fields and scopes of research […]

Attending to the Interests and Needs of the Bio Defense Community

Over the past decade, the United States government has allocated nearly $55 billion on preparing the nation against biological threats. The Obama administration has maintained that momentum with a total biodefense budget of $6.05 billion for FY2012, going primarily to the NIH and DOD. Additional civilian biodefense funds have been budgeted to the DHS, USDA, […]

SBIR/STTR & Beyond – Common Misperceptions

One of the most common misperceptions relating to non-dilutive funding for life science R&D is that the SBIR/STTR program is the main and even only funding resource available for the life science industry. Companies and investors alike must know that although it is an important and sometimes relevant program, the SBIR/STTR program is a small, […]

Last Minute Applications

Writing proposals for Federal grants is a time consuming task that requires much planning and administration. This process typically takes 3-6 weeks to complete for a standard high quality application; more complex applications may take longer. However, the brief periods often allotted between release of a funding opportunity announcement and its deadline, as well as […]